推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 從4月24日中國醫(yī)藥保健品進(jìn)出口商會在京召開的“CPhI&P-MEC中國展周年慶典活動啟動儀式”上獲悉，2015年，醫(yī)保商會將繼續(xù)推出植物提取物國際商務(wù)標(biāo)準(zhǔn)，擴(kuò)大標(biāo)準(zhǔn)的覆蓋面，并開展提取物生產(chǎn)過程的相關(guān)國際認(rèn)證，推動提升我國植物提取物行業(yè)國際競爭力。
醫(yī)保商會擬制定的標(biāo)準(zhǔn)包括：淫羊藿提取物、白芍提取物、綠咖啡豆提取物、靈芝提取物、葛根提取物等。其中淫羊藿提取物和綠咖啡豆提取物將與美國藥典共同合作，標(biāo)準(zhǔn)完成后雙方直接互認(rèn)。此外，醫(yī)保商會還擬與美國國家衛(wèi)生基金會(NSF)合作開展提取物生產(chǎn)過程的相關(guān)國際認(rèn)證(GEP認(rèn)證)和推薦工作。
植物提取物一直是中藥產(chǎn)品出口大類，自醫(yī)保商會2013年發(fā)布首批植物提取物國際商務(wù)標(biāo)準(zhǔn)以來，填補(bǔ)了國內(nèi)提取物標(biāo)準(zhǔn)空白。
